Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Advances in the Neurobiology of Mental Illness

WEBINAR

Only

FREE Event

Advances in the Neurobiology of Mental Illness

Monday, May 24, 2021, 10:15 AM - 5:10 PM EDT

Webinar

Presented By

The New York Academy of Sciences

 

Mental and neurological disorders impact one in four people worldwide, with approximately 450 million people currently suffering from conditions that impact emotion, thinking, and/or behavior. Depression alone accounts for 4.3% of the global burden of diseases and is among the largest single causes of disability worldwide. Substantial health, social, and economic burdens are associated with mental health issues, further compounding the difficulties that accompany these disorders.

This symposium will provide a neutral forum for scientists, physicians, clinicians, other allied healthcare providers, policy makers, and patients across a range of academic, clinical, industry, and government sectors to explore new scientific understanding of the neurobiology of mental illnesses. Plenary presentations will focus on genetics, genomics, neuroimmunology, brain imaging, computational psychiatry, behavior regulation, schizophrenia, major depression, and more. In addition to exploring the basic science underlying these illnesses, the symposium will also explore avenues for translating the basic science into treatments.

Registration

Speakers

Alan Anticevic
Alan Anticevic, PhD

Yale School of Medicine

Deanna Barch
Deanna Barch, PhD

Washington University in St. Louis

Bill Martin, PhD
Bill Martin, PhD

The Janssen Pharmaceutical Companies of Johnson & Johnson

Patrick McGorry
Patrick D. McGorry, PhD

University of Melbourne

Benjamin Neale, PhD
Benjamin Neale, PhD

Broad Institute of MIT and Harvard,

Beth Stevens, PhD
Beth Stevens, PhD

Harvard Medical School, Boston Children’s Hospital, HHMI

Consuelo Walss-Bass
Consuelo Walss-Bass, PhD

University of Texas McGovern Medical School

Sponsor

Monday

May 24, 2021

10:15 AM

Welcome Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
10:30 AM

Historical Perspective on Biological Psychiatry

Speaker

Bill Martin, PhD
The Janssen Pharmaceutical Companies of Johnson & Johnson
11:10 AM

Patient-Derived Brain-Based Mechanistic Studies of Psychiatric Disorders

Speaker

Consuelo Walss-Bass, PhD
University of Texas McGovern Medical School
11:50 AM

Break

12:00 PM

Elucidating the Genetic Architecture of Psychiatric Disorders

Speaker

Benjamin Neale, PhD
Broad Institute of MIT and Harvard
12:40 PM

Quantifying the Brain-Behavioral Space across the Psychosis Spectrum for Neuroscience-Guided Therapeutic Target Selection

Speaker

Alan Anticevic, PhD
Yale School of Medicine
1:20 PM

Lunch break

2:10 PM

Mechanisms of Motivational and Cognitive Deficits in Psychiatric Illness

Speaker

Deanna Barch, PhD
Washington University in St. Louis
2:50 PM

The Role of Microglia in Serious Mental Illnesses

Speaker

Beth Stevens, PhD
Harvard Medical School, Boston Children’s Hospital, HHMI
3:30 PM

Break

3:50 PM

Clinical Staging in Psychiatry: Making Diagnosis Work for Patients, Clinicians and Researchers

Speaker

Patrick D. McGorry, PhD
University of Melbourne
4:30 PM

Panel Discussion

Speakers

Moderator: Bill Martin, PhD
The Janssen Pharmaceutical Companies of Johnson & Johnson
Panelists: To be announced
5:15 PM

Closing Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
5:20 PM

Symposium Adjourns